TBPH

TBPH

USD

Theravance Biopharma Inc. Ordinary Shares

$14.750-0.110 (-0.740%)

Preço em tempo real

Healthcare
Biotecnologia
Estados Unidos

Gráfico de preços

Loading Chart...

Métricas-chave

Métricas de mercado
Fundamentos da empresa
Estatísticas de negociação

Métricas de mercado

Abertura

$14.860

Máximo

$15.001

Mínimo

$14.420

Volume

0.49M

Fundamentos da empresa

Capitalização de mercado

742.8M

Setor

Biotecnologia

País

United States

Estatísticas de negociação

Volume médio

0.42M

Bolsa de valores

NGM

Moeda

USD

Faixa de 52 semanas

Mínimo $7.9Atual $14.750Máximo $15.335

Notícias relacionadas

PR Newswire

Theravance Biopharma to Present Data on Ampreloxetine at the 36th International Symposium on The Autonomic Nervous System

Theravance Biopharma, Inc. (NASDAQ: TBPH) today announced that it will be participating at the 36th International Symposium on the Autonomic Nervous...

Ver mais
Theravance Biopharma to Present Data on Ampreloxetine at the 36th International Symposium on The Autonomic Nervous System
PR Newswire

Theravance Biopharma to Report Third Quarter 2025 Financial Results on November 10, 2025

Theravance Biopharma, Inc. (NASDAQ: TBPH) will report its third quarter 2025 financial results and provide a business update after market close on...

Ver mais
Theravance Biopharma to Report Third Quarter 2025 Financial Results on November 10, 2025
PR Newswire

Theravance Biopharma to Present New Analyses Highlighting YUPELRI® (revefenacin) Outcomes in COPD at the 2025 CHEST Annual Meeting

Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH), today announced that it will be presenting two rapid-fire...

Ver mais
Theravance Biopharma to Present New Analyses Highlighting YUPELRI® (revefenacin) Outcomes in COPD at the 2025 CHEST Annual Meeting

Mantenha-se atualizado

Defina um alerta de preço, obtenha atualizações de análise de IA e notícias de mercado em tempo real.